91桃色

ISSN: 2161-0681

Journal of Clinical & Experimental Pathology
Open 91桃色

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open 91桃色 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open 91桃色 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Citations : 2975

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • Cosmos IF
  • Ulrich's Periodicals Directory
  • RefSeek
  • Directory of Research Journal Indexing (DRJI)
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
  • world cat
  • journal seek genamics
  • j-gate
  • esji (eurasian scientific journal index)
Share This Page

Strategies for implementation of digital pathology as a primary diagnostic tool

9th World Digital Pathology & Pathologists Congress

Samar Betmouni

University of Bradford, UK

Posters & Accepted Abstracts: J Clin Exp Pathol

DOI:

Abstract
In the UK, the importance of innovation in pathology is recognized in a recent NHS England report (Digital First: Clinical transformation through pathology innovation). Digital Pathology (DP) is such an innovation with a potential to transform the delivery of diagnostic histopathology services. At the end of 2015, the DP market was valued at US$327 Million, with a significant increase in market value forecast. However, whilst there have been significant increases in market value along with advances in DP, primary diagnostic use of this technology in the UK is not widespread. Internationally, there are several examples of digital pathology (DP) utilization in Africa; North, South and Central America; Mexico; Asia (Japan, India) and Europe. The main drive for implementation of DP in some countries is the unmet need of the population for quality diagnostic services and appropriately trained staff. This talk will describe the diagnostic histopathology landscape in the UK and discuss strategies that may be adopted to improve the uptake of this technology as a primary diagnostic tool. This will include our own work, in partnership with Philips Digital Pathology Solutions to improve DP training and awareness. Examples of diagnostic DP implementation will be reviewed in order to assess how such examples can inform strategies to improve adoption of DP in the UK.
Biography

Email: S.Betmouni@bradford.ac.uk

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top